Literature DB >> 9951515

Effect of amifostine (Ethyol) on the development of extraembryonic blood vessels in chick embryos.

J Höper1, A Hanjalic, R Sauer, L Plasswilm.   

Abstract

AIM: Systemic and local side effects can limit radio- as well as chemotherapy in patients suffering from neoplastic diseases. One possibility to reduce the therapy-dependent side effects is to attenuate radical induced alterations of normal healthy tissue by application of antioxidants. Preclinical and clinical studies demonstrated the ability of amifostine to protect normal, but not neoplastic, tissues from cytotoxic effects of chemotherapy or irradiation. The purpose of the present study was to establish whether amifostine (Ethyol) can affect microvessel density in vivo.
MATERIAL AND METHODS: For this study fertilized crossbred "White-Plymouth-Rocks x Sussex" eggs were used. After 48 hours of incubation 0.05 ml solution containing 25.7 micrograms (approximately 120 microM) amifostine were injected next to the germ disc. Taking into account the mean surface area of the are vasculosa and the embryo, this corresponds to a dose of 26 micrograms/cm2. As controls, the area vasculosa of eggs treated with 0.05 ml NaCl 0.9% were used. Twenty-four and 48 hours after injection of amifostine or NaCl photographs and video microscopic pictures from treated areas and controls were taken and evaluated for vascular density. Results of vascular density are given as vascular intersections per mm2 (VIS/mm2).
RESULTS: There was a significant (p < 0.001) difference in vascular density with a mean microvessel count of 30.40 (+/- 12.84 SD) VIS/mm2 in the NaCl control and 53.69 (+/- 24.56 SD) VIS/mm2 in the amifostine-treated area vasculosa.
CONCLUSION: The results show that amifostine induced an increase in vascular density in the rapidly proliferating area vasculosa of the early chick embryo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9951515     DOI: 10.1007/BF02743458

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  18 in total

1.  Localized areas of high alkaline phosphatase activity in endothelium of arteries.

Authors:  F C ROMANUL; R G BANNISTER
Journal:  Nature       Date:  1962-08-11       Impact factor: 49.962

2.  Cysteine Protection against X Irradiation.

Authors:  H M Patt; E B Tyree; R L Straube; D E Smith
Journal:  Science       Date:  1949-08-26       Impact factor: 47.728

3.  Radioprotection of cells in culture by WR-2721 and derivatives: form of the drug responsible for protection.

Authors:  G D Smoluk; R C Fahey; P M Calabro-Jones; J A Aguilera; J F Ward
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

4.  Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum(II) by WR-2721 without altering its antitumor properties.

Authors:  J M Yuhas; F Culo
Journal:  Cancer Treat Rep       Date:  1980-01

5.  The role of WR-2721 in radiotherapy and/or chemotherapy.

Authors:  J M Yuhas; J M Spellman; F Culo
Journal:  Cancer Clin Trials       Date:  1980

6.  The modification of melphalan toxicity in tumor bearing mice by s-2-(3-aminopropylamino)- ethylphosphorothioic acid (WR 2721).

Authors:  J L Millar; T J McElwain; R D Clutterbuck; E A Wist
Journal:  Am J Clin Oncol       Date:  1982-06       Impact factor: 2.339

7.  Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.

Authors:  J M Yuhas
Journal:  Cancer Res       Date:  1980-05       Impact factor: 12.701

8.  Uptake of WR-2721 derivatives by cells in culture: identification of the transported form of the drug.

Authors:  P M Calabro-Jones; J A Aguilera; J F Ward; G D Smoluk; R C Fahey
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

9.  Use of radiation with or without WR-2721 in advanced rectal cancer.

Authors:  T Liu; Y Liu; S He; Z Zhang; M M Kligerman
Journal:  Cancer       Date:  1992-06-01       Impact factor: 6.860

10.  Time dependence of the selective modulation of cisplatin-induced nephrotoxicity by WR2721 in the mouse.

Authors:  M Treskes; E Boven; U Holwerda; H M Pinedo; W J van der Vijgh
Journal:  Cancer Res       Date:  1992-04-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.